Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Acta Derm Venereol ; 104: adv19460, 2024 Mar 14.
Article in English | MEDLINE | ID: mdl-38483083

ABSTRACT

Since December 2019, the COVID-19 pandemic has profoundly affected healthcare. The real effects of the COVID-19 pandemic on skin cancer are still unclear, more than 3 years later. This study aims to summarise the pandemic's impact on skin cancer diagnosis and outcome. A systematic review and meta-analysis was conducted, selecting studies comparing skin cancer diagnosis and prognosis post-pandemic with pre-pandemic data. A total of 27 papers were reviewed including 102,263 melanomas and 271,483 keratinocyte carcinomas. During the initial pandemic months (January-July 2020), melanoma surgeries dropped by 29.7% and keratinocyte carcinomas surgeries by 50.8%. Early pandemic tumours exhibited greater thickness and stage. In a long-term period beyond the initial months, melanoma surgeries decreased by 9.3%, keratinocyte carcinomas by 16.6%. No significant differences were observed in the Breslow thickness of melanomas after the start of the pandemic (mean difference 0.06, 95% confidence interval -0.46, 0.58). Melanomas operated on post-pandemic onset had an increased risk of ulceration (odds ratio 1.35, 95% confidence interval 1.22-1.50). Keratinocyte carcinomas showed increased thickness and worsened stage post-pandemic. However, studies included were mostly retrospective and cross-sectional, reporting diverse data. This review indicates that the pandemic likely caused delays in skin cancer diagnosis and treatment, potentially impacting patient outcomes.


Subject(s)
COVID-19 , Keratinocytes , Melanoma , Skin Neoplasms , Humans , COVID-19/epidemiology , Skin Neoplasms/epidemiology , Skin Neoplasms/pathology , Skin Neoplasms/diagnosis , Skin Neoplasms/surgery , Melanoma/epidemiology , Melanoma/surgery , Melanoma/diagnosis , Keratinocytes/pathology , SARS-CoV-2 , Prognosis , Neoplasm Staging
2.
J Arthroplasty ; 36(1): 387-394, 2021 01.
Article in English | MEDLINE | ID: mdl-32826144

ABSTRACT

BACKGROUND: The increasing use of orthopedic total hip arthroplasty implants has led to a consequent rise in the incidence of associated periprosthetic fractures (PPFs). Analysis of the National Joint Registry data showed the choice of cemented hip stem influenced the risk of a PPF occurring. However, the effect of implant design in relation to the risk of PPFs has not been investigated. METHODS: The main objective is to compare the biomechanics of PPFs as a failure of the Exeter V40, CPT, and DePuy C-Stem stems in a composite Sawbone model to identify whether a difference in the risk of fracture exists between them. Twenty-six Sawbones were divided into 3 groups, cemented with the Stryker Exeter, Zimmer CPT, or DePuy C-Stem and then torqued to fracture. RESULTS: When compared with the Exeter, the CPT- and C-Stem-implanted Sawbone models would sustain PPFs at a statistically significantly lower rotation to failure (20.1° and 26.7° vs 33.6°, P < .01) and torque to failure (124 Nm and 143 Nm vs 174 Nm, P < .01) values. The energy release rate at failure for the Exeter was significantly higher than that for the CPT and C-Stem (61.2 Nm vs 21.8 Nm and 38.6 Nm, P < .01), which led to more comminution. CONCLUSION: The CPT- and C-Stem-implanted femurs, although fracturing earlier, fractured in a simple pattern with less comminution. The differences in stem design mean higher stress at the critical point of failure in the CPT implanted femur compared with the Exeter and DePuy, which is likely the reason behind the observed increased risk of PPFs with the CPT implant.


Subject(s)
Arthroplasty, Replacement, Hip , Femoral Fractures , Hip Prosthesis , Periprosthetic Fractures , Arthroplasty, Replacement, Hip/adverse effects , Femoral Fractures/epidemiology , Femoral Fractures/etiology , Femoral Fractures/surgery , Femur/surgery , Hip Prosthesis/adverse effects , Humans , Periprosthetic Fractures/epidemiology , Periprosthetic Fractures/etiology , Periprosthetic Fractures/surgery , Prosthesis Design
4.
SAE Int J Adv Curr Pract Mobil ; 1(2): 601-638, 2019.
Article in English | MEDLINE | ID: mdl-32803170

ABSTRACT

As part of the U.S. Environmental Protection Agency's (EPA's) continuing assessment of advanced light-duty automotive technologies in support of regulatory and compliance programs, a 2018 Toyota Camry A25A-FKS 4-cylinder, 2.5-liter, naturally aspirated, Atkinson Cycle engine with cooled exhaust gas recirculation (cEGR) was benchmarked. The engine was tested on an engine dynamometer with and without its 8-speed automatic transmission, and with the engine wiring harness tethered to a complete vehicle parked outside of the test cell. Engine and transmission torque, fuel flow, key engine temperatures and pressures, onboard diagnostics (OBD) data, and Controller Area Network (CAN) bus data were recorded. This paper documents the test results under idle, low, medium, and high load engine operation. Motoring torque, wide open throttle (WOT) torque and fuel consumption are measured during transient operation using both EPA Tier 2 and Tier 3 test fuels. The design and performance of this 2018 2.5-liter engine is described and compared to Toyota's published data and to EPA's previous projections of the efficiency of an Atkinson Cycle engine with cEGR. The Brake Thermal Efficiency (BTE) map for the Toyota A25A-FKS engine shows a peak efficiency near 40 percent, which is the highest value of any publicly available map for a non-hybrid production gasoline internal combustion (IC) engine designed to run on 91 RON fuel. Further improvement is possible by application of fixed discrete or full continuous cylinder deactivation, both of which are currently in production on other engines.

5.
SAE Int J Engines ; 11(6): 1273-1305, 2018.
Article in English | MEDLINE | ID: mdl-31275509

ABSTRACT

As part of the U.S. Environmental Protection Agency's (EPA's) continuing assessment of advanced light-duty automotive technologies to support the setting of appropriate national greenhouse gas standards and to evaluate the impact of new technologies on in- use emissions, a 2016 Honda Civic with a 4-cylinder 1.5-liter L15B7 turbocharged engine and continuously variable transmission (CVT) was benchmarked. The test method involved installing the engine and its CVT in an engine dynamometer test cell with the engine wiring harness tethered to its vehicle parked outside the test cell. Engine and transmission torque, fuel flow, key engine temperatures and pressures, and onboard diagnostics (OBD)/CAN bus data were recorded. This paper documents the test results for idle, low, medium and high load engine operation, as well as motoring torque, wide-open throttle torque and fuel consumption during transient operation using both EPA Tier 2 and Tier 3 test fuels. Particular attention is given to characterizing enrichment control during high load engine operation. Results are used to create complete engine fuel consumption and efficiency maps and estimate CO2 emissions using EPA's ALPHA full vehicle simulation model, over regulatory drive cycles. The design and performance of the 1.5-liter Honda engine are compared to several other past, present, and future downsized-boosted engines and potential advancements are evaluated.

SELECTION OF CITATIONS
SEARCH DETAIL